Antiemetic Serotonin 5-HT3 Receptor Antagonists

All categories
DBCAT005718Pharmacologic class

A class of antiemetic medications used to prevent nausea and vomiting among patients undergoing chemotherapy, radiotherapy or surgery. These drugs work by selectively blocking serotonin 5-HT3 receptors. A DrugBank category of 5 drugs. 5 of them are approved.

Part of
Antiemetics
Drugs

What you can answer from here — as of July 22, 2022

5DrugsEach linked to its full drug card
Listed above
8Drug targetsEvery drug–target pair in the class, with bond type
Sign in
2,220Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
11Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Antiemetic Serotonin 5-HT3 Receptor Antagonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In